1 April 2024 false No description of principal activity Taxfiler 2024.6 07153043business:PrivateLimitedCompanyLtd2024-04-012025-03-31 071530432024-03-31 071530432024-04-012025-03-31 07153043business:AuditExempt-NoAccountantsReport2024-04-012025-03-31 07153043business:AbridgedAccounts2024-04-012025-03-31 071530432025-03-31 07153043business:Director12024-04-012025-03-31 07153043business:Director22024-04-012025-03-31 07153043business:RegisteredOffice2024-04-012025-03-31 071530432024-03-31 07153043core:WithinOneYear2025-03-31 07153043core:WithinOneYear2024-03-31 07153043core:AfterOneYear2025-03-31 07153043core:AfterOneYear2024-03-31 07153043core:ShareCapitalcore:PreviouslyStatedAmount2025-03-31 07153043core:ShareCapitalcore:PreviouslyStatedAmount2024-03-31 07153043core:RetainedEarningsAccumulatedLossescore:PreviouslyStatedAmount2025-03-31 07153043core:RetainedEarningsAccumulatedLossescore:PreviouslyStatedAmount2024-03-31 07153043core:PreviouslyStatedAmount2025-03-31 07153043core:PreviouslyStatedAmount2024-03-31 07153043business:SmallEntities2024-04-012025-03-31 07153043countries:EnglandWales2024-04-012025-03-31 07153043core:MotorVehicles2024-04-012025-03-31 07153043business:OrdinaryShareClass12024-04-012025-03-31 07153043business:OrdinaryShareClass12023-04-012024-03-31 071530432023-04-012024-03-31 iso4217:GBP xbrli:shares xbrli:pure
Company Registration No. 07153043 (England and Wales)
Pharm-I-Link Limited Unaudited accounts for the year ended 31 March 2025
Pharm-I-Link Limited Unaudited accounts Contents
Page
- 2 -
Pharm-I-Link Limited Company Information for the year ended 31 March 2025
Directors
Tausif Hameed Sabur Subani Shabir
Company Number
07153043 (England and Wales)
Registered Office
1st Floor New Mill Village Store Holmfir New Mill Holmfirth England HD9 7JY United Kingdom
- 3 -
Pharm-I-Link Limited Statement of financial position as at 31 March 2025
2025 
2024 
Notes
£ 
£ 
Fixed assets
Tangible assets
7,857 
8,358 
Current assets
Inventories
35,000 
35,000 
Debtors
137,460 
108,713 
Cash at bank and in hand
107,357 
107,830 
279,817 
251,543 
Creditors: amounts falling due within one year
(185,507)
(147,043)
Net current assets
94,310 
104,500 
Total assets less current liabilities
102,167 
112,858 
Creditors: amounts falling due after more than one year
(23,166)
(23,166)
Net assets
79,001 
89,692 
Capital and reserves
Called up share capital
100 
100 
Profit and loss account
78,901 
89,592 
Shareholders' funds
79,001 
89,692 
For the year ending 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
The members have agreed to the preparation of abridged accounts for the year in accordance with Section 444(2A).
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board of Directors and authorised for issue on 10 July 2025 and were signed on its behalf by
Tausif Hameed Director Company Registration No. 07153043
- 4 -
Pharm-I-Link Limited Notes to the Accounts for the year ended 31 March 2025
1
Statutory information
Pharm-I-Link Limited is a private company, limited by shares, registered in England and Wales, registration number 07153043. The registered office is 1st Floor New Mill Village Store Holmfir, New Mill, Holmfirth, England, HD9 7JY, United Kingdom.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
3
Accounting policies
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous year, and also have been consistently applied within the same accounts.
Basis of preparation
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
Presentation currency
The accounts are presented in £ sterling.
Turnover
Turnover represents the value, net of VAT and discounts, of goods provided to customers and work carried out in respect of services provided to customers.
Tangible fixed assets policy
Depreciation has been provided at the following rates in order to write off the assets over their estimated useful lives. Depreciation is not charged on assets in the year of acquisition.
Motor vehicles
6%
Stocks
Stocks and work-in-progress are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items. Cost includes all direct expenditure.
4
Tangible fixed assets
Total 
£ 
Cost or valuation
At 1 April 2024
9,913 
At 31 March 2025
9,913 
Depreciation
At 1 April 2024
1,555 
Charge for the year
501 
At 31 March 2025
2,056 
Net book value
At 31 March 2025
7,857 
At 31 March 2024
8,358 
- 5 -
Pharm-I-Link Limited Notes to the Accounts for the year ended 31 March 2025
5
Share capital
2025 
2024 
£ 
£ 
Allotted, called up and fully paid:
100 Ordinary shares of £1 each
100 
100 
6
Average number of employees
During the year the average number of employees was 7 (2024: 11).
- 6 -